Alisa Hummings

Nov 9, 2023 | clinicalleader.com | Alisa Hummings |Simon Johns |James Riddle

Medidata has a seat at the table where regulatory change happens. Our input helps accelerate your innovations into the marketplace. Proof-Of-Concept Study Enabled To Drive Novel Gene Therapy ProgramUnearth how a natural history trial aimed at addressing an exceptionally rare neurological disease affecting pediatric patients with no existing treatment options was executed successfully.

Oct 26, 2023 | clinicalleader.com | Laura McWhinney |Austin Roberts |Alisa Hummings

Webinar: Breaking Barriers — Meeting Diversity Goals In Clinical Trials Through Innovative Smart Trial Design StrategiesLearn how technology can help to identify and select the right sites and investigators for your therapeutic area as we explore strategies for tracking and reporting on your patient diversity goals. Click here to learn more. Win The Small And Emerging Sponsors’ Service ContractsWhat affects the decision made by small and emerging sponsors to engage with a service provider?

Feb 17, 2023 | clinicalleader.com | Alisa Hummings |Simon Johns |Steve Gens

One Surprising Reason Wearables Stalled A Clinical Trial Video | Clinical Leader Live Clinical trial technologies have been innovated and introduced into clinical research with the hope of making trials quicker, easier, and more accurate — for all parties involved. But what happens when the approach isn’t as patient-centric as intended? Janssen Clinical Innovation’s Bert Hartog describes how using one particular wearable nearly derailed a study.